Erratum: Evaluation of a new formulation of epoprostenol sodium in Japanese patients with a pulmonary arterial hypertension (EPITOME4) (Advances in Therapy DOI:10.1007/s12325-013-0029-0)

Yuichi Tamura; Tomohiko Ono; Keiichi Fukuda; Toru Satoh; Shigetake Sasayama

doi:10.1007/s12325-013-0031-6

Erratum: Evaluation of a new formulation of epoprostenol sodium in Japanese patients with a pulmonary arterial hypertension (EPITOME4) (Advances in Therapy DOI:10.1007/s12325-013-0029-0)

Yuichi Tamura, Tomohiko Ono, Keiichi Fukuda, Toru Satoh, Shigetake Sasayama

Department of Internal Medicine (Cardiology)

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	554-555
Number of pages	2
Journal	Advances in Therapy
Volume	30
Issue number	5
DOIs	https://doi.org/10.1007/s12325-013-0031-6
Publication status	Published - 2013 May

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.1007/s12325-013-0031-6

Cite this

Erratum: Evaluation of a new formulation of epoprostenol sodium in Japanese patients with a pulmonary arterial hypertension (EPITOME4) (Advances in Therapy DOI:10.1007/s12325-013-0029-0). / Tamura, Yuichi; Ono, Tomohiko; Fukuda, Keiichi et al.
In: Advances in Therapy, Vol. 30, No. 5, 05.2013, p. 554-555.

Research output: Contribution to journal › Comment/debate › peer-review

@article{f9e1c84be0f8496db0732ca7eae4ccd7,

title = "Erratum: Evaluation of a new formulation of epoprostenol sodium in Japanese patients with a pulmonary arterial hypertension (EPITOME4) (Advances in Therapy DOI:10.1007/s12325-013-0029-0)",

author = "Yuichi Tamura and Tomohiko Ono and Keiichi Fukuda and Toru Satoh and Shigetake Sasayama",

year = "2013",

month = may,

doi = "10.1007/s12325-013-0031-6",

language = "English",

volume = "30",

pages = "554--555",

journal = "Advances in Therapy",

issn = "0741-238X",

publisher = "Health Communications Inc.",

number = "5",

}

TY - JOUR

T1 - Erratum

T2 - Evaluation of a new formulation of epoprostenol sodium in Japanese patients with a pulmonary arterial hypertension (EPITOME4) (Advances in Therapy DOI:10.1007/s12325-013-0029-0)

AU - Tamura, Yuichi

AU - Ono, Tomohiko

AU - Fukuda, Keiichi

AU - Satoh, Toru

AU - Sasayama, Shigetake

PY - 2013/5

Y1 - 2013/5

UR - http://www.scopus.com/inward/record.url?scp=84879246235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879246235&partnerID=8YFLogxK

U2 - 10.1007/s12325-013-0031-6

DO - 10.1007/s12325-013-0031-6

M3 - Comment/debate

AN - SCOPUS:84879246235

SN - 0741-238X

VL - 30

SP - 554

EP - 555

JO - Advances in Therapy

JF - Advances in Therapy

IS - 5

ER -

Erratum: Evaluation of a new formulation of epoprostenol sodium in Japanese patients with a pulmonary arterial hypertension (EPITOME4) (Advances in Therapy DOI:10.1007/s12325-013-0029-0)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this